Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest digestive disease Stories

2014-03-11 16:26:53

ATLANTIC CITY, N.J., March 11, 2014 /PRNewswire/ -- A jury in New Jersey returned a $1.59 million verdict to a former Accutane user against N.J.-based pharmaceutical companies Hoffmann La-Roche Inc. and Roche Laboratories. The plaintiff, Kamie Kendall Rees, was prescribed several courses of Accutane for treatment of her acne in the 1990s, starting at the age 12. Shortly thereafter, Ms. Kendall Rees developed ulcerative colitis--a permanent, debilitating disease. Unable to manage...

2013-12-22 23:00:10

Diverticulitis Breakthrough, written by Mark Anastasi, is the latest book that teaches people how to improve their digestive system and regain their health naturally. Sherri Davis from the site HealthReviewCenter.com performed a detailed Diverticulitis Breakthrough review that indicates if this book is worth buying. Seattle, WA (PRWEB) December 22, 2013 Diverticulitis is a common digestive disease that involves the formation of pouches (diverticula) within the bowel wall. Diverticulitis...

2013-10-11 12:24:54

EMBARGOED FOR RELEASE, Monday, October 14, 2013, 8:00 a.m. EDT SAN DIEGO, Oct. 11, 2013 /PRNewswire-USNewswire/ -- More than 4,000 gastroenterologists, physicians and other health care professionals from around the world will convene this week for the American College of Gastroenterology's (ACG) 78(th) Annual Scientific Meeting at the San Diego Convention Center in San Diego, CA, to review and present the latest scientific advances in gastrointestinal research, treatment of digestive...

2013-06-21 23:04:27

Bridgestone Retail Operations Customer Round-Up Campaign Supports the Crohn’s & Colitis Foundation of America Bala Cynwyd, PA (PRWEB) June 21, 2013 The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce that for the months of July and August, Bridgestone Retail Operations, LLC (BRSO) will raise money for Crohn’s disease and ulcerative colitis with a nationwide “round-up” program. BSRO employees and its 2,200 retail locations nationwide, including...

2013-05-21 08:29:00

ORLANDO, Fla., May 21, 2013 /PRNewswire-USNewswire/ -- Research presented today at Digestive Disease Week® (DDW) explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease. While coffee consumption recently has been associated with reduced risk of fibrosis, a new study found that even a few more cups of java each month also correlate with lower risk for a particular autoimmune liver disease. Researchers at the Mayo Clinic,...

Coffee Lowers Risk Of Autoimmune Liver Disease
2013-05-19 07:29:04

redOrbit Staff & Wire Reports - Your Universe Online Regular coffee consumption has been linked to a reduced risk of the autoimmune liver disease primary sclerosing cholangitis (PSC), according to a study that will be presented by Mayo Clinic researchers at the Digestive Disease Week 2013 conference in Orlando, Florida on Monday. According to the Minnesota-based medical center, PSC is a disease of the bile ducts, which can result in inflammation and subsequent duct obstruction...

2012-12-13 12:24:26

OAKLAND, Calif., Dec. 13, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2013 Innovator Awards Program for Inflammatory Bowel Disease (IBD). The Program supports "out-of-the-box" innovative research projects that are potentially transformative to the Foundation's efforts to diagnose, treat and/or cure IBD. The Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research...

2012-09-13 02:27:20

PRINCETON, N.J., Sept. 13, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the company), a development stage biopharmaceutical company announced today that the US Patent Office granted patent 8,263,582 entitled "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of beclomethasone dipropionate (BDP) in orally administered dosage forms that act...

2012-08-24 06:23:32

OAKLAND, Calif., Aug. 24, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation (KRF) announced today the recipients of its 2012 Innovator Awards and its 2012 Breakthrough Awards for Inflammatory Bowel Disease (IBD) research. Innovator Award recipients will each receive a $100,000 grant to support their respective innovative research projects. Breakthrough Awards are extended to existing KRF Innovator Award recipients, whose projects have demonstrated significant promise of...

2012-07-23 22:20:40

GOTHENBURG, Sweden, July 24, 2012 /PRNewswire/ -- Albireo AB (Gothenburg, Sweden; "Albireo"), a biopharmaceutical company specializing in gastroenterology, today announced that the European Medicines Agency Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on an application for orphan medicinal product status for the company's lead hepatology candidate, A4250, for the treatment of: - Primary Biliary Cirrhosis (PBC) -...